JASPER THERAPEUTICS, INC.
JSPRW -1.5
EPS (as of 2023-12-31)
Use left/right arrow keys to switch.Breakdowns
| Name | Value |
|---|
| Revenues | 2.1M |
| Cost of Revenue | 0.3M |
| Gross Profit | 1.8M |
| Operating Expense | 17.4M |
| Operating I/L | -17.7M |
| Other Income/Expense | 1.1M |
| Interest Income | 1.2M |
| Pretax | -16.6M |
| Income Tax Expense | 1.9M |
| Net Income/Loss | -16.6M |
Jasper Therapeutics, Inc.
Trending Profiles
This is the ALPHA version. The tool and data may contain incorrect information. Please read it with caution.
